Carisma Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Carisma Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 52% to $14,919,000. Profit margin reached -582%. Total operating expenses were $103,650,000.
Profit Margin
| 2014 | 2.24M | -34.53M | -1539.55% |
|---|---|---|---|
| 2015 | 990K | -33.45M | -3378.99% |
| 2016 | 29.98M | 1.89M | 6.31% |
| 2017 | 425K | -29.02M | -6830.35% |
| 2018 | 0 | -33.69M | |
| 2019 | 0 | -107.5M | |
| 2020 | 11.23M | -28.32M | -252.05% |
| 2021 | 26.54M | -40.77M | -153.61% |
| 2022 | 9.83M | -61.22M | -622.6% |
| 2023 | 14.91M | -86.87M | -582.34% |
CARM Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 14.91M | 9.83M | 26.54M | 11.23M | 0 | 0 | 425K | 29.98M | 990K | 2.24M |
Cost of revenue | 74.12M | 6.09M | 85K | 0 | 219K | 0 | 0 | 0 | 0 | 0 |
Gross profit | -59.20M | 3.74M | 26.45M | 11.23M | -219K | 0 | 425K | 29.98M | 990K | 2.24M |
Operating exp. | ||||||||||
Research and development | 74.12M | 56.61M | 34.38M | 23.29M | 24.44M | 14.07M | 12.22M | 13.47M | 25.97M | 26.70M |
Selling and marketing | 0 | 30.40M | 0 | 0 | 0 | 0 | -170K | 0 | 0 | 0 |
Total operating expenses | 103.65M | 59.90M | 40.79M | 28.37M | 36.65M | 25.7M | 20.12M | 28.21M | 35.82M | 35.17M |
Operating income | -88.73M | -56.16M | -40.79M | -28.37M | -36.87M | -33.69M | -19.98M | 2.14M | -35.19M | -33.78M |
Other income (expenses), net | 1.85M | -5.06M | 10K | 29K | -70.62M | 0 | -9.04M | -247K | 1.74M | -1.22M |
Income before tax | -86.87M | -61.22M | -40.78M | -28.34M | -107.5M | -33.69M | -29.02M | 1.89M | -33.45M | -34.15M |
Income tax expense | 0 | -3.87M | -10K | -29K | 0 | 0 | 0 | 5K | 1.39M | 376K |
Net income | -86.87M | -61.22M | -40.77M | -28.32M | -107.5M | -33.69M | -29.02M | 1.89M | -33.45M | -34.53M |
Earnings per share | ||||||||||
Basic EPS | -2.59 | -575.42 | -4.47 | -4.79 | -23.64 | -10.91 | -22.24 | 1.79 | -35.23 | -47.16 |
Diluted EPS | -2.59 | -575.42 | -4.47 | -4.79 | -23.64 | -10.91 | -22.24 | 1.74 | -35.23 | -47.16 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |